Aleksandra Szulc Selected Research

Arabinofuranosylcytosine Triphosphate

11/2016	Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
11/2015	Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksandra Szulc Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 05/2015
3	Leukemia 05/2017 - 11/2015
1	Hypoxia (Hypoxemia) 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2016

Drug/Important Bio-Agent (IBA)

4	Dendrimers (Dendrons)IBA 01/2019 - 11/2015
2	Small Interfering RNA (siRNA)IBA 01/2019 - 05/2015
2	Arabinofuranosylcytosine TriphosphateIBA 11/2016 - 11/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2016 - 11/2015
2	NucleosidesIBA 11/2016 - 11/2015
1	carbosilaneIBA 01/2019
1	fluoromisonidazoleIBA 01/2018
1	pimonidazoleIBA 01/2018
1	poly(propyleneimine)IBA 11/2016
1	Pharmaceutical PreparationsIBA 11/2016
1	MaltoseIBA 11/2016
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2016
1	triphosphoric acid (triphosphate)IBA 11/2016
1	Cytidine Triphosphate (CTP)IBA 11/2015
1	pyrimidineIBA 11/2015
1	nasIBA 11/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2016
1	Therapeutics 11/2016